Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter


THE pROBLEM Conflicting results of two major randomized trials on prostate cancer mortality (1, 2) have led to evolving guidelines for clinicians regarding prostate cancer screening (3–6). While the European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that one prostate cancer death could be prevented per 781 men screened, the Prostate… (More)
DOI: 10.3389/fonc.2016.00235

1 Figure or Table


  • Presentations referencing similar topics